期刊文献+

左乙拉西坦治疗儿童癫痫的疗效及安全性观察 被引量:3

The effects and security of levetiracetam in children with epilepsy
下载PDF
导出
摘要 目的:研究左乙拉西坦对于不同类型癫痫患儿的临床疗效及其安全性。方法:将各种不同发作类型的64例癫痫患儿分为单药治疗组47例和添加治疗组17例。单药治疗组应用左乙拉西坦治疗,添加治疗组因之前用药未能控制癫痫发作进而添加左乙拉西坦进行联合治疗,观察两组治疗结果。结果:单药治疗组有效率为83%(39/47例),添加治疗组为65%(11/17例),两组总有效率比较差异无统计学意义(x2=1.48,P〉0.05)。部分性发作总有效率为85%(34/40例),全面性发作总有效率为63%(15/24例),二者比较差异有统计学意义(x2=4.23,P〈0.05)。此外,简单部分性发作、复杂部分性发作、部分性发作继发全面性发作、婴儿痉挛、强直阵挛发作以及肌阵挛发作的有效率均在60%以上。单药治疗组与添加治疗组不良反应均较少且轻微,差异无统计学意义(x2=0.05,P〉0.05)。结论:左乙拉西坦治疗儿童各型癫痫均有良好的疗效,不良反应少。 Objective:To explore the effect and security of Levetiracetam for children with different kinds of epilepsy. Methods: Sixty-four patients were divided into the monotherapy group (n=47) and the add-on therapy group(n= 17). The monotherapy group was given Levetiracetam. When seizures were not controlled by other AEDs, the patients received levetiracetam as add-on therapy. All patients were followed up for 6 months to establish the effect and security. Results; The effective rate of the monotherapy group was 83 %(39/47), and the add-on therapy group was 65 % (11/17). No significant difference in effective rate was found between the two groups (X2 = 1.48, P〉0. 05). The effective rate of patial seizures in the two groups was 85%(34/40), and of general seizures was 63% (15/24). There was significant difference in effective rate on various epilepsy (X2 = 4.23, P〈0.05). Moreover, the effectiveness in partial epilepsy, West syndrome, tonic clonic seizure, and myoclonic seizure was more than 60%. The side effect of both monotherapy group and add-on therapy were less and mild, and there was no significant difference(x2=0.05, P〉0.05). Conclusion: Levetiracetam has satisfactory effect and fewer side effect for children with different kinds of epilepsy.
作者 陈波
出处 《癫痫与神经电生理学杂志》 2011年第6期335-337,351,共4页 Journal of Epileptology and Electroneurophysiology(China)
关键词 癫痫 儿童 左乙拉西坦 治疗 Epilepsy Levetiracetam Therapy,Children
  • 相关文献

参考文献6

二级参考文献37

  • 1刘照,肖波,丁玲舒,孔亮,林佑成,江利敏.青少年肌阵挛性癫临床特点分析[J].中华神经科杂志,2006,39(4):265-266. 被引量:8
  • 2汤业磊,张进,丁美萍,楼敏,周祥琴.青少年肌阵挛性癫87例临床及治疗特点分析[J].中华神经科杂志,2006,39(5):316-319. 被引量:5
  • 3周波,周东,田林郁,洪震,肖军.左乙拉西坦添加治疗对部分性癫癎患者认知功能及生活质量的研究[J].中华神经科杂志,2007,40(3):154-156. 被引量:10
  • 4林礼务.现代超声临床诊断:第一版[M].厦门:厦门大学出版社,.173.
  • 5Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepiIeptic drug levetiracetam[J]. Proc Natl Acad Sci U S A JT-Proceedings of the National Academy of Sciences of the United States of America, 2004,101 (26): 9861-9866.
  • 6Zona C, Niespodziany I, Marchetti C, et al. Levetiracetam does not modulate neuronal voltage-gated Na ^+ and T-type Ca2+ currents[J]. Seizure JTSeizure : the journal of the British Epilepsy Association, 2001,10(4) :279-286.
  • 7Khurana DS, Kothare SV, Valencia I, et al. Levetiracetam monotherapy in children with epilepsy[J]. Pediatr Neurol JT- Pediatric neurology,2007,36(4):227-230.
  • 8Verrotti A, Cerminara C, Coppola G, et al. Levetiracetam in juvenile myoclonic epilepsy: long term efficacy in newly diagnosed adolescents[J]. Dev Med Child Neurol JT Developmen tal medicine and child neurology, 2008, 50(1 ):29-32.
  • 9Chhun S, Jullien V, Rey E, et al. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy [ J ]. Epilepsia ,2009,50(5 ) : 1150 - 1157.
  • 10Ulloa CM, Towfigh A, Safdieh J. Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial - onset seizures [ J]. Neuropsychiatr Dis Treat ,2009,5 : 467 - 476.

共引文献20

同被引文献44

  • 1肖侠明.儿童癫痫现代诊断与治疗[J].中华妇幼临床医学杂志(电子版),2006,2(2):115-117. 被引量:11
  • 2Vezzani A, Granata T. Brain inflammation in epilepsy : Experimental and clinical evidence [ j ]. Epilepsia, 2005,6 ( 11 ) : 1740 - 1743.
  • 3Sutula TP, Hagen J, Pitkanen A. Do epileptic seizures damage the brain [J]. Curt Opin Neural,2003,16(2) :189 -195.
  • 4Vezzani A, Balosso S, Ravizza T. The role of cytokines in the patho- physiology of epilepsy [ J ]. Brain Behav Immun, 2008,22 ( 6 ) : 797 - 803.
  • 5Klobuenikova K, Kollar B, Martiniskova Z. Daytime sleepiness and chan- ges of sleep architecture in patients with epilepsy [ J ]. Neural Endocrinol Lett,2011,30(5) :521 -524.
  • 6Schiemann-Delgado J, Yang H, Loge Cde L, ct al. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures[J]. Child Neurol, 2012, 27(1): 80-89.
  • 7Popov IV, Iakovleva IA. Dynamics of cognitive and emotional- volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2013, 3 (5): 48-52.
  • 8Faa G, Ekstrom J, Castagnola M, et al. A developmental approach to drug-induced liver injury in newborns and children[J]. Curr Med Chem, 2012, 19(27): 4581-4594.
  • 9Sivkova SN, Mukhin KIuj Zaikova FM. Efficacy of treatment of focal forms of epilepsy in children with antiepileptic drugs of different generations[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2011, 11(6): 42-48.
  • 10Tumay Y, Mtun Y, Ekmekci K, et al. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients [J]. Clin Neuropharmacol, 2013, 6 (2): 55-58.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部